Arcutis Biotherapeutics (ARQT) Goodwill & Intangibles (2022 - 2025)
Arcutis Biotherapeutics has reported Goodwill & Intangibles over the past 4 years, most recently at $14.8 million for Q4 2025.
- Quarterly results put Goodwill & Intangibles at $14.8 million for Q4 2025, up 56.26% from a year ago — trailing twelve months through Dec 2025 was $14.8 million (up 56.26% YoY), and the annual figure for FY2025 was $14.8 million, up 56.26%.
- Goodwill & Intangibles for Q4 2025 was $14.8 million at Arcutis Biotherapeutics, down from $15.4 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for ARQT hit a ceiling of $16.5 million in Q1 2025 and a floor of $6.1 million in Q2 2024.
- Median Goodwill & Intangibles over the past 4 years was $7.3 million (2022), compared with a mean of $9.7 million.
- Biggest five-year swings in Goodwill & Intangibles: fell 11.0% in 2024 and later surged 164.0% in 2025.
- Arcutis Biotherapeutics' Goodwill & Intangibles stood at $7.2 million in 2022, then dropped by 10.43% to $6.4 million in 2023, then soared by 47.24% to $9.5 million in 2024, then surged by 56.26% to $14.8 million in 2025.
- The last three reported values for Goodwill & Intangibles were $14.8 million (Q4 2025), $15.4 million (Q3 2025), and $15.9 million (Q2 2025) per Business Quant data.